Year: 2023
WHO grade 1 tumour.
Nuclear Beta catenin – Adamantinomatous Cr. (CTNNB1 mutation)
BRAF-V600E – Papillary Cr.
Can infect CNS. But treated with antibiotics.
Load More
Histopathology study desk for FRCPath – Part 1
Histopathology study desk for FRCPath – Part 1
WHO grade 1 tumour.
Nuclear Beta catenin – Adamantinomatous Cr. (CTNNB1 mutation)
BRAF-V600E – Papillary Cr.
Can infect CNS. But treated with antibiotics.